Cargando…
Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?
Central nervous system (CNS) involvement in anaplastic large cell lymphoma (ALCL) at diagnosis is rare and leads to poor prognosis with the use of the standard ALCL99 protocol alone. CNS-directed intensive chemotherapy, such as an increased dose of intravenous MTX, increased dose of dexamethasone, i...
Autores principales: | Tanaka, Makito, Miura, Hiroki, Ishimaru, Soichiro, Furukawa, Gen, Kawamura, Yoshiki, Kozawa, Kei, Yamada, Seiji, Ito, Fumitaka, Kudo, Kazuko, Yoshikawa, Tetsushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302098/ https://www.ncbi.nlm.nih.gov/pubmed/37368362 http://dx.doi.org/10.3390/pediatric15020029 |
Ejemplares similares
-
Primary CNS ALK-negative anaplastic large cell lymphoma: A case report and review of the literature
por: Brady, Amy L., et al.
Publicado: (2023) -
TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild-type ALK and ALK-resistant Mutations
por: Murray, Brion W., et al.
Publicado: (2021) -
Cumulative incidence rates for CNS and non-CNS progression in two phase II studies of alectinib in ALK-positive NSCLC
por: Gadgeel, Shirish, et al.
Publicado: (2018) -
Immune Response against ALK in Children with ALK-Positive Anaplastic Large Cell Lymphoma
por: Stadler, Serena, et al.
Publicado: (2018) -
Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
por: Wang, Yuan, et al.
Publicado: (2022)